Avidian Wealth Solutions, LLC Natera, Inc. Transaction History

Avidian Wealth Solutions, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	BUY	$36.57 - $58.29 $144,305 - $230,012	3,946 New	3,946 $219,000
Q1 2022 May 10, 2022	SELL	$30.32 - $91.33 $112,881 - $340,021	-3,723 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $61,072 - $84,252	-708 Reduced 15.98%	3,723 $348,000
Q3 2021 Nov 10, 2021	BUY	$100.17 - $126.36 $223,479 - $281,909	2,231 Added 101.41%	4,431 $494,000
Q2 2021 Aug 09, 2021	BUY	$86.05 - $119.72 $189,310 - $263,384	2,200 New	2,200 $250,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Avidian Wealth Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Avidian Wealth Solutions, LLC with notifications on news.